637 Views | 335 Downloads
Corresponding author. Mailing address: Dept. of Radiation Oncology, Emory University, 1365 Clifton Road, NE, Suite CT-104, Atlanta, GA 30322. Phone: (404) 778-2161. Fax: (404) 778-4139. hgshu@emory.edu.
We thank P. Raychaudhuri for providing pCMV-T7FOXM1 and 6×FOX-luciferase reporter, Y. Feng for providing pCSrcA-HA14, T.J. Murphy for providing pTJ105 (MuLV luciferase vector), and C. Hadjipanayis for providing lysates from U87MG control and EGFRvIII-expressing cells.
Authors' Contributions: Conception and design: K. Xu, H.-K.G. Shu Development of methodology: K. Xu, H.-K.G. Shu Acquisition of data (provided animals, acquired and managed patients, provided facilities, etc.): K. Xu, H.-K.G. Shu Analysis and interpretation of data (e.g., statistical analysis, biostatistics, computational analysis): K. Xu, H.-K.G. Shu Writing, review, and/or revision of the manuscript: K. Xu, H.-K.G. Shu Administrative, technical, or material support (i.e., reporting or organizing data, constructing databases): K. Xu, H.-K.G. Shu Study supervision: H.-K.G. Shu
Conflict of Interest: None.
This work was supported, in part, by a Cancer Center grant from the National Cancer Institute (P30-CA138292).
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
© 2013 American Association for Cancer Research.